172 related articles for article (PubMed ID: 12567893)
1. [Antagonistic effect of hydroxysafflor yellow A on the platelet activating factor receptor].
Zang BX; Jin M; Si N; Zhang Y; Wu W; Piao YZ
Yao Xue Xue Bao; 2002 Sep; 37(9):696-9. PubMed ID: 12567893
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor].
Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):789-91. PubMed ID: 15506296
[TBL] [Abstract][Full Text] [Related]
3. [Antagonistic effect of myricetin on platelet activing factor].
Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
Yao Xue Xue Bao; 2003 Nov; 38(11):831-3. PubMed ID: 14991995
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of hydroxysafflor yellow A against PMN activation induced by LPS].
Wu W; Jin M; Tong J; Wang XF; Zang BX
Yao Xue Xue Bao; 2011 Feb; 46(2):153-7. PubMed ID: 21542285
[TBL] [Abstract][Full Text] [Related]
5. Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: binding and in vitro functional studies.
Castro-Faria-Neto HC; Bozza PT; Cruz HN; Silva CL; Violante FA; Barbosa-Filho JM; Thomas G; Martins MA; Tibiriçá EV; Noel F
Planta Med; 1995 Apr; 61(2):101-5. PubMed ID: 7753913
[TBL] [Abstract][Full Text] [Related]
6. [Protective effect of hydroxysafflor yellow A on experimental cerebral ischemia in rats].
Zhu HB; Wang ZH; Tian JW; Fu FH; Liu K; Li CL
Yao Xue Xue Bao; 2005 Dec; 40(12):1144-6. PubMed ID: 16496682
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
[TBL] [Abstract][Full Text] [Related]
8. Piperbetol, methylpiperbetol, piperol A and piperol B: a new series of highly specific PAF receptor antagonists from Piper betle.
Zeng HW; Jiang YY; Cai DG; Bian J; Long K; Chen ZL
Planta Med; 1997 Aug; 63(4):296-8. PubMed ID: 9270371
[TBL] [Abstract][Full Text] [Related]
9. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
10. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of hydroxysafflor yellow A on focal cerebral ischemic injury in rats and its primary mechanisms.
Zhu HB; Zhang L; Wang ZH; Tian JW; Fu FH; Liu K; Li CL
J Asian Nat Prod Res; 2005 Aug; 7(4):607-13. PubMed ID: 16087635
[TBL] [Abstract][Full Text] [Related]
12. Hydroxysafflor yellow A (HSYA) targets the platelet-activating factor (PAF) receptor and inhibits human bronchial smooth muscle activation induced by PAF.
Guo X; Zheng M; Pan R; Zang B; Gao J; Ma H; Jin M
Food Funct; 2019 Aug; 10(8):4661-4673. PubMed ID: 31292579
[TBL] [Abstract][Full Text] [Related]
13. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
14. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X
Int J Tissue React; 1985; 7(5):339-43. PubMed ID: 2997065
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies.
Zhu H; Wang Z; Ma C; Tian J; Fu F; Li C; Guo D; Roeder E; Liu K
Planta Med; 2003 May; 69(5):429-33. PubMed ID: 12802724
[TBL] [Abstract][Full Text] [Related]
16. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
Marquis O; Robaut C; Cavero I
J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
[TBL] [Abstract][Full Text] [Related]
17. Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin.
Hsu HC; Yang WC; Tsai WJ; Chen CC; Huang HY; Tsai YC
Biochem Biophys Res Commun; 2006 Jul; 345(3):1033-8. PubMed ID: 16712790
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Alberts AW; Bugianesi RL; Chabala JC; Ponpipom MM
J Pharmacol Exp Ther; 1988 Aug; 246(2):534-41. PubMed ID: 2841449
[TBL] [Abstract][Full Text] [Related]
19. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
20. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation.
Zhang M; Zhang LZ; Lu JS
Zhongguo Yao Li Xue Bao; 1995 May; 16(3):209-12. PubMed ID: 7660812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
